Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 846-851

  Colgan, Richard ^a   Johnson, James R ^b   Kuskowski, Michael ^b   Gupta, Kalpana ^c,d,e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c YALE UNIVERSITY   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RISK FACTOR; URINALYSIS; URINE CULTURE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, URINARY; CYSTITIS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINE;

EID: 40549090897     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01200-07     Document Type: Article

References (27)

1. Brown, P. D., A. Freeman, and B. Foxman. 2002. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin. Infect. Dis. 34:1061-1066.
2. Burman, W. J., P. E. Breese, B. E. Murray, K. V. Singh, H. A. Batal, T. D. MacKenzie, J. W. Ogle, M. L. Wilson, R. R. Reves, and P. S. Mehler. 2003. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am. J. Med. 115: 358-364.
3. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
4. Gupta, K., T. M. Hooton, P. Roberts, and W. Stamm. 2007. Short-course nitrofurantoin for the treatment of uncomplicated acute cystitis in women. Arch. Intern. Med. 167:2207-2212.
5. Gupta, K., T. M. Hooton, and W. E. Stamm. 2005. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. J. Antimicrob. Chemother. 56:243-246.
6. Gupta, K., and W. E. Stamm. 2002. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int. J. Antimicrob. Agents 19:554-556.
7. Hillier, S., J. Bell, M. Heginbothom, Z. Roberts, F. Dunstan, A. Howard, B. Mason, and C. C. Butler. 2006. When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. J. Antimicrob. Chemother. 58:1303-1306.
8. Hooton, T. M., R. Besser, B. Foxman, T. R. Fritsche, and L. E. Nicolle. 2004. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin. Infect. Dis. 39:75-80.
9. Huang, E. S., and R. S. Stafford. 2002. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch. Intern. Med. 162:41-47.
10. Hummers-Pradier, E., M. Koch, A. M. Ohse, W. R. Heizmann, and M. M. Kochen. 2005. Antibiotic resistance of urinary pathogens in female general practice patients. Scand. J. Infect. Dis. 37:256-261.
11. Johnson, J. R., A. R. Manges, T. T. O'Bryan, and L. W. Riley. 2002. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359:2249-2251.
12. Johnson, J. R., A. C. Murray, M. A. Kuskowski, S. Schubert, M. F. Prere, B. Picard, R. Colodner, and R. Raz. 2005. Distribution and characteristics of Escherichia coli clonal group A. Emerg. Infect. Dis. 11:141-145.
13. Johnson, J. R., K. Owens, A. R. Manges, and L. W. Riley. 2004. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J. Clin. Microbiol. 42:2618-2622.
14. Kallen, A. J., H. G. Welch, and B. E. Sirovich. 2006. Current antibiotic therapy for isolated urinary tract infections in women. Arch. Intern. Med. 166:635-639.
15. Manges, A. R., J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, and L. W. Riley. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345:1007-1013.
16. Mentler, P. A., B. R. Kuhn, and G. Gandhi. 2006. Risk stratification for trimethoprim-sulfamethoxazole resistance in community-acquired, uncomplicated urinary tract infections. Am. J. Health Syst. Pharm. 63:1588-1590.
17. Metlay, J. P., B. L. Strom, and D. A. Asch. 2003. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole- resistant urinary tract infections. J. Antimicrob. Chemother. 51:963-970.
18. O'Neill, P. M., C. A. Talboys, A. P. Roberts, and B. S. Azadian. 1990. The rise and fall of Escherichia coli O15 in a London teaching hospital. J. Med. Microbiol. 33:23-27.
19. Petrof, E. O., D. N. Schwartz, and J. P. Quinn. 2002. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 346:535-536.
20. Raz, R., B. Chazan, Y. Kennes, R. Colodner, E. Rottensterich, M. Dan, I. Lavi, and W. Stamm. 2002. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin. Infect. Dis. 34:1165-1169.
21. Sandel, D. C., C. T. Wang, and S. Kessler. 2002. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 346: 535-536.
22. Sannes, M. R., E. A. Belongia, B. Kieke, K. E. Smith, A. Kieke, M. Vandermause, J. Bender, C. Clabots, P. L. Winokur, and J. R. Johnson. Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J. Infect. Dis., in press.
23. Stamm, W. E. 2007. Evaluating guidelines. Clin. Infect. Dis. 44:775-776.
24. Steinke, D. T., R. A. Seaton, G. Phillips, T. M. MacDonald, and P. G. Davey. 2001. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J. Antimicrob. Chemother. 47:781-787.
25. Taur, Y., and M. A. Smith. 2007. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin. Infect. Dis. 44:769-774.
26. Warren, J. W., E. Abrutyn, J. R. Hebel, J. R. Johnson, A. J. Schaeffer, W. E. Stamm, et al. 1999. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin. Infect. Dis. 29:745-758.
27. Wright, S. W., K. D. Wrenn, and M. L. Haynes. 1999. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J. Gen. Intern. Med. 14:606-609.